Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Victoria V O'Connor"'
Publikováno v:
The American Surgeon. 88:2345-2350
Background Management of hepatocellular adenoma (HA) is marked by a paucity of recent studies. Long-term follow-up data from an equal access health care system may facilitate our understanding of the natural disease course of HA and identify modifiab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b184031e3f74621ef602162912f940
https://doi.org/10.1177/00031348211011084
https://doi.org/10.1177/00031348211011084
Autor:
Simon Lavotshkin, Daniel W. Nelson, Michael Sung, Victoria V O'Connor, David D. Lee, Louis A. DiFronzo, Jonathan Fergus
Publikováno v:
HPB. 22:1703-1710
BACKGROUND Pancreatectomy in early pancreas adenocarcinoma has been historically underutilized. This retrospective study examines recent trends in the use of pancreatectomy in clinical Stage I (T1-2N0M0) pancreas cancer. METHODS Using the 2004-2014 N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e69bc6829ba307ad70045f5358edf84
https://doi.org/10.1016/j.hpb.2020.03.017
https://doi.org/10.1016/j.hpb.2020.03.017
Autor:
Bethany M Heidenreich, Julia O. Bader, Remigio J Flor, Timothy J. Vreeland, Victoria V O'Connor, Daniel W. Nelson, Phillip M. Kemp Bohan
Publikováno v:
World Journal of Surgery. 45:531-542
Surgical debulking of primary neuroendocrine tumors (NETs) and hepatic resection of metastatic NET disease may each independently improve overall survival. However, evidence for combined primary site debulking and metastasectomy on survival and impac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c623491dccbff20ff428012bc136d8be
https://doi.org/10.1007/s00268-020-05847-x
https://doi.org/10.1007/s00268-020-05847-x
Publikováno v:
Journal of Surgical Oncology. 123:164-171
Adjuvant chemotherapy for cholangiocarcinoma (CCA) has not been shown to gain significant improvements in survival. Factors contributing to suboptimal treatment response include aggressive disease biology and late clinical presentation. When feasible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf00efd2bfcfe10b88168d928d10c9b5
https://doi.org/10.1002/jso.26230
https://doi.org/10.1002/jso.26230
Publikováno v:
Journal of Surgical Research. 245:51-56
Background For patients with pancreatic adenocarcinoma (PA), the optimal time interval between neoadjuvant chemoradiation (CR) to surgical resection has not been well established. Methods The National Cancer Database from 2006 to 2014 was queried for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190d38572239d0a96beef050a3778861
https://doi.org/10.1016/j.jss.2019.07.024
https://doi.org/10.1016/j.jss.2019.07.024
Publikováno v:
The American surgeon. 88(6)
Background Peritoneal lavage cytology (PLC) can detect advanced disease in gastric adenocarcinoma (GC); however, routine practice remains controversial. Furthermore, the effect of neoadjuvant chemotherapy (NAC) on cytological detection of carcinomato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25274701b8a6b7c0850172705ac94c8
https://pubmed.ncbi.nlm.nih.gov/33382351
https://pubmed.ncbi.nlm.nih.gov/33382351
Autor:
Michael Sung, Stephanie Young, Mayo Hotta, Anna M. Leung, Stefanie Sueda, Victoria V O'Connor
Publikováno v:
The American surgeon. 86(10)
Appendiceal mucinous neoplasm (AMN) can present with a spectrum of disease. Predicting factors in development of pseudomyxoma peritonei (PMP) from AMN could aid in management and treatment. The aim of this study was to determine factors predictive of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72b6beee60da2856986ac99d5786466
https://pubmed.ncbi.nlm.nih.gov/33284666
https://pubmed.ncbi.nlm.nih.gov/33284666
Publikováno v:
The American surgeon. 86(10)
Enhanced recovery protocols (ERPs) have shown to improve outcomes in multiple specialties and were recently applied to hepatic resections. The objective of this study was to determine the safety and efficacy of ERP in hepatic resection. Between 2013-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ceb3d85df0679168f3c84f1f8baa289
https://pubmed.ncbi.nlm.nih.gov/33125262
https://pubmed.ncbi.nlm.nih.gov/33125262
Publikováno v:
The American surgeon. 86(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f90e6b3c57cd5cfde067ab8b3be8c74
https://pubmed.ncbi.nlm.nih.gov/32223814
https://pubmed.ncbi.nlm.nih.gov/32223814
Publikováno v:
HPB. 20:834-840
Background In a single trial, perioperative pasireotide demonstrated reduction in postoperative pancreatic fistula (POPF) following pancreatectomy, yet recent studies question the efficacy of this drug. Methods All patients who underwent pancreatic r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdcf7e402e09963d854f701799f07c1a
https://doi.org/10.1016/j.hpb.2018.03.007
https://doi.org/10.1016/j.hpb.2018.03.007